In this sense, a study revealed that Rb2 activates BAT and induces browning of WAT, which increases energy expenditure and thermogenesis and consequently ameliorates obesity and metabolic disorders, suggesting Rb2 to be a promising beneficial compound treating obesity [153]. The gene discussed is RBL2; the disease is obesity due to melanocortin 4 receptor deficiency.